CKIP-1在肿瘤免疫微环境中的功能及其作用机制研究进展OA
Research Progress on Role and Mechanism of CKIP-1 in Tumor Immune Micro-environment
酪蛋白激酶2相互作用蛋白1(CKIP-1)是一种包含pleckstrin同源(PH)结构域的多功能支架蛋白,具有动态亚细胞定位能力,通过调控肿瘤免疫微环境(TIME)中的免疫代谢及信号网络,在肿瘤进展中发挥"促癌"或"抑癌"的双重作用.本文系统归纳了CKIP-1的结构特征及其在TIME中的调控机制,揭示其可通过抑制巨噬细胞M2极化、拮抗Smurf1介导的致癌蛋白泛素化降解、调控TGF-β及PI3K/AKT等信号通路等.现有证据表明,靶向CKIP-1有望增强免疫检查点抑制剂(ICIs)或CAR-T疗法的抗肿瘤效应,但其临床转化仍面临组织特异性机制不清、联合治疗毒性风险等挑战.本综述整合了CKIP-1在肿瘤免疫微环境中的调控知识,为开发基于CKIP-1的精准免疫治疗提供理论支持,并进一步解析其动态调控机制以推进临床转化.
Casein kinase 2-interacting protein-1(CKIP-1)is a multifunctional scaffold protein with a pleckstrin homology domain.Its dynamic subcellular localization enables dual roles in tumor progression,"promoting"or"suppressing"malignancy by regulating immune metabolism and signaling networks within the tumor immune microenvironment(TIME).This review synthesizes current knowledge on CKIP-1's structural characteristics and TIME regulatory mechanisms.We highlight that CKIP-1 inhibits macrophage M2 polarization,antagonizes Smurf1-mediated oncoprotein ubiquitination,and modulates key pathways,including TGF-β and PI3K/AKT.Targeting CKIP-1 enhances the efficacy of immune checkpoint inhibitors and CAR-T therapy,but clinical translation faces challenges,such as unclear tissue-specific mechanisms and combination toxicity.This review aims to synthesize the regulatory functions of CKIP-1 in the tumor immune microenvironment,thereby offering a theoretical basis for precision immunotherapy targeting CKIP-1 and further analyzing its dynamic mechanisms to advance clinical applications.
曹真文;吉茹
010000 呼和浩特,内蒙古医科大学附属肿瘤医院病理科(北京大学肿瘤医院内蒙古医院)010000 呼和浩特,内蒙古医科大学附属肿瘤医院病理科(北京大学肿瘤医院内蒙古医院)
医药卫生
CKIP-1肿瘤免疫微环境Smurf1免疫逃避免疫治疗
CKIP-1Tumor immune microenvironmentSmurf1Immune evasionImmunotherapy
《肿瘤防治研究》 2026 (3)
219-225,7
High-level Clinical Specialty Construction Science and Technology Project of Peking University Cancer Hospital,Inner Mongolia Branch(No.2024YNYB003)Sub-project of High-level Clinical Specialty Development Science and Technology Project of Public Hospitals in Inner Mongolia Autonomous Region(No.2023SGGZ072) 北京大学肿瘤医院内蒙古医院高水平临床专科建设科技项目(2024YNYB003)内蒙古自治区公立医院高水平临床专科发展科技项目(2023SGGZ072)
评论